Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
SituGen is a medical device startup that has developed a comprehensive system for extracting stem-cell-rich umbilical cord blood.
The companys patented SG1040 is a disposable, all-inclusive, non-contaminating collection kit designed to increase the quality of cord blood and the number of stem cells extracted. The novel device is needle-free, preventing the bottleneck effect associated with needles.
SituGen is an Israel-based company and part of the Rad-Bynet Group of multinational technology companies.